Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media

被引:127
作者
Rapola, S
Jäntti, V
Haikala, R
Syrjänen, R
Carlone, GM
Sampson, JS
Briles, DE
Paton, JC
Takala, AK
Kilpi, TM
Käyhty, H
机构
[1] Natl Publ Hlth Inst, Dept Vaccines, Helsinki 00300, Finland
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
[3] Univ Alabama, Birmingham, AL USA
[4] Womens & Childrens Hosp, Adelaide, SA, Australia
关键词
D O I
10.1086/315822
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pneumococcal surface protein A (PspA), pneumococcal surface adhesin A (PsaA), and pneumolysin (Ply) are common to virtually all Streptococcus pneumoniae isolates. They are immunogenic and protective against pneumococcal challenge in animals and are the major candidates for a protein-based pneumococcal vaccine for humans. However, little is known of the natural development of antibodies to these proteins in humans. The objective of this study was to evaluate the natural development of antibodies to PspA, PsaA, and Ply in relation to pneumococcal infection and carriage in young children. Serum antibodies to these proteins were measured by EIA in children at ages 6, 12, 18, and 24 months and in their mothers. All age groups were capable of producing antibodies to the 3 proteins. The antibody concentrations increased with age and were strongly associated with pneumococcal exposure, whether by carriage or infection (acute otitis media).
引用
收藏
页码:1146 / 1152
页数:7
相关论文
共 30 条
[1]  
ADES EW, 1998, PNEUM VACC WORLD C W, P30
[2]   IMMUNIZATION OF MICE WITH PNEUMOLYSIN TOROID CONFERS A SIGNIFICANT DEGREE OF PROTECTION AGAINST AT LEAST 9 SEROTYPES OF STREPTOCOCCUS-PNEUMONIAE [J].
ALEXANDER, JE ;
LOCK, RA ;
PEETERS, CCAM ;
POOLMAN, JT ;
ANDREW, PW ;
MITCHELL, TJ ;
HANSMAN, D ;
PATON, JC .
INFECTION AND IMMUNITY, 1994, 62 (12) :5683-5688
[3]  
BLACK S, 1999, 39 INT C ANT AG CHEM, P379
[4]   PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice [J].
Briles, DE ;
King, JD ;
Gray, MA ;
McDaniel, LS ;
Swiatlo, E ;
Benton, KA .
VACCINE, 1996, 14 (09) :858-867
[5]   Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine [J].
Dagan, R ;
Melamed, R ;
Muallem, M ;
Piglansky, L ;
Greenberg, D ;
Abramson, O ;
Mendelman, PM ;
Bohidar, N ;
Yagupsky, P .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1271-1278
[6]  
ESKOLA J, 1999, 39 INT C ANT AG CHEM
[7]   Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae [J].
Ghaffar, F ;
Friedland, IR ;
Mccracken, GH .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (07) :638-646
[8]   The epidemiology of pneumococcal infection in children in the developing world [J].
Greenwood, B .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1384) :777-785
[9]   MEASUREMENT OF ANTIBODY-RESPONSES TO PNEUMOLYSIN - A PROMISING METHOD FOR THE PRESUMPTIVE ETIOLOGICAL DIAGNOSIS OF PNEUMOCOCCAL PNEUMONIA [J].
JALONEN, E ;
PATON, JC ;
KOSKELA, M ;
KERTTULA, Y ;
LEINONEN, M .
JOURNAL OF INFECTION, 1989, 19 (02) :127-134
[10]   PNEUMOCOCCAL POLYSACCHARIDE-MENINGOCOCCAL OUTER-MEMBRANE PROTEIN COMPLEX CONJUGATE VACCINE IS IMMUNOGENIC IN INFANTS AND CHILDREN [J].
KAYHTY, H ;
AHMAN, H ;
RONNBERG, PR ;
TILLIKAINEN, R ;
ESKOLA, J .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05) :1273-1278